Short answer · Medically reviewed summary · Last updated: 2026-05-08
Androgen Insensitivity Syndrome (AIS) is a condition where an individual, who is genetically male (XY), is resistant to androgens, leading to a spectrum of physical traits that may appear female or intermediate. Symptoms vary significantly based on the degree of receptor sensitivity, ranging from complete external female development to ambiguous genitalia or mild virilization. What are the primary symptoms of Androgen Insensitivity Syndrome? In cases of Complete Androgen Insensitivity Syndrome (CAIS), individuals are born with typical external female genitalia and are often raised as female.
Androgen Insensitivity Syndrome (AIS) is a condition where an individual, who is genetically male (XY), is resistant to androgens, leading to a spectrum of physical traits that may appear female or intermediate. Symptoms vary significantly based on the degree of receptor sensitivity, ranging from complete external female development to ambiguous genitalia or mild virilization.
In cases of Complete Androgen Insensitivity Syndrome (CAIS), individuals are born with typical external female genitalia and are often raised as female. The most characteristic clinical feature is the absence of a uterus, fallopian tubes, and upper vagina, as well as the presence of undescended testes in the abdomen or inguinal canal. In Partial Androgen Insensitivity Syndrome (PAIS), symptoms are more variable and may include ambiguous genitalia at birth, hypospadias, or micropenis.
Early signs often appear during puberty or infancy. For those with CAIS, the most common indicator is primary amenorrhea (the absence of menstruation) despite normal breast development. In PAIS, physicians may notice atypical genital development during newborn screening. The severity of Androgen Insensitivity Syndrome is strictly dependent on the functionality of the androgen receptor, leading to a wide phenotypic spectrum:
Quality of life concerns often focus on fertility and the psychological impact of living with a difference in sexual development. Because individuals with Androgen Insensitivity Syndrome have internal testes, there is a lifelong risk of gonadal malignancy (testicular tumors). Consequently, many patients require specialized endocrine and surgical management throughout their lives to monitor hormone levels and address potential surgical needs for the undescended testes.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.